Home › Pancreatic Cancer › Nevada › Las Vegas

Pancreatic Cancer clinical trials in Las Vegas, NV

4 studies for Pancreatic Cancer are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

RecruitingPhase 3

Comprehensive Cancer Centers, Las Vegas

Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07562152

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

RecruitingPhase 3

Comprehensive Cancer Centers of Nevada, Las Vegas

Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07252232

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

RecruitingPhase 2

Ohio State University-Telemedicine, Las Vegas

Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

RecruitingObservational study

OptumCare Cancer Care at Charleston, Las Vegas
Urology Specialists of Nevada - Southwest, Las Vegas
Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas
and 7 more

Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT06073431

About Pancreatic Cancer

The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.

More about Pancreatic Cancer on MedlinePlus

Pancreatic Cancer trials in other cities

Other studies in Las Vegas

From ClinicalTrials.gov, data retrieved Oct 7, 2026. Each study sets its own eligibility; the study team decides who can join.